In the present investigation an attempt was made to prepare colon targeted enteric coated tablet containing different prednisolone solid dispersion formulations, to prevent ulcerative colitis, improve the patient compliance and reduce the side effects of drug in the gastro intestinal tract (GIT). Solid dispersion is one of the most widely used approaches to enhance the solubility as well as dissolution rate of poorly water soluble drugs. Solid dispersions (SDs) of Prednisolone with D-mannitol, PEG 4000 and Kollicoat IR were prepared and evaluated to deliver Prednisolone to the colon in a pre-solubilized form. The selected formula using drug compatible excipients was compressed into fast disintegrating tablets and then coated with Eudragit S100 (pH-responsive polymer), several variables related to both solid dispersion preparation (carrier type and drug to the carrier ratio) and tablet coating (coat level) were studied to show their effects on drug solubility and dissolution. Different analytical techniques like differential scanning caloremitry (DSC), powder x-ray diffraction (PXRD) and scanning electron microscopy (SEM) were studied to prove the change of drug particle from crystal to amorphous form in SDs. The 1:3 Prednisolone/Kollicoat IR SDs showed the greatest improvement in the dissolution rate. The coating level was critical for determining the duration of the lag phase. Best result was given by the 16% coat (Eudragit S100/ Dibutyl phthalate/ talc). This coating level showed an acceptable lag time for the proposed colonic targeting (5 h) as the selected tablet resisted pre-colonic pH values, followed by an immediate release stage in pH 7.4. The suggested covered (coated) tablets may provide a colonic delivery system for prednisolone with enhanced solubility and bioavailability.
Introduction
In the last few years, the development of the site specific drug delivery system has been introduced to be studied with great deal of research work which compromises numerous benefits over the traditional drug treatments. The principle goal of the site specific delivery is to deliver the drug in the specific organs of the body Improvement of the dissolution rates of class II water-insoluble drugs is one of the most challenging issues of drug development, because the enhanced dissolution rates can enhance drug oral bioavailability 7 . For water-insoluble drugs the solid dispersion technique established by Chiou and Reigelman supplies an effective way to increase the dissolution rates of drugs 8 .
In the present study, efforts were made to improve the dissolution behavior and consequently, absorption, of Prednisolone by applying the solid dispersion technique using three different hydrophilic carriers (PEG 4000, D-mannitol and Kollicoat IR) the solid dispersion formulations were compressed into tablets and further coated to deliver the drug to colon.
Materials and Methods

Materials
Prednisolone, D-mannitol, Crospovidone, Croscarmellose sodium, magnesium stearate were obtained from Samara drug industry, Iraq;
Kollicoat IR was obtained from Sigma-Aldrich Co., USA; Poly ethylene glycol (PEG4000) from Sinopharm chemical reagent Co., China, Eudragit S100 was purchased from Evonik Company,
Germany
and Dibutyl phthalate was manufactured by Fluka
Company, UK. All other chemicals, reagents and solutions used were of analytical grade. Marketed tablet Deltacortril® (Pfizer, Turkey) was purchased from local pharmacy.
Methods
Solubility determination of Prednisolone
For the determination of solubility of Prednisolone, an excess amount of the drug about 50 mg was added to 25 ml phosphate buffers pH7.4. The flask was stirred for 24 hours using magnetic stirrer and maintained at 25 o C. The sample was then filtered through 0.45 μm membrane filters, suitably diluted, and analyzed by UVspectrophotometer at 247 for prednisolone. The study was performed in triplicate [9] [10] [11] .
Preparation of Prednisolone solid dispersions
Solid dispersions of prednisolone in three hydrophilic carriers at three different weight ratios were prepared by solvent evaporation method by using ethanol as common solvent. The calculated amount of polymer and drug was dissolved separately in the required amount of solvent ethanol and mixed under mechanical agitation. The solvent was eliminated using a rotary evaporator under reduced pressure. The solid dispersions when dried were grinded using a mortar and pestle then passed through 0.36 mm sieve and stored in desiccators till use 12 , and the optimum one for each carrier was compared with the physical mixture and pure Prednisolone. Solid dispersion and physical mixture of different weight ratios are listed in 4 and compared to that of pure drug 13, 14 . 
Selection of the best formula
The phase solubility and in vitro dissolution test were used for selecting the best solid dispersion formula which will be subjected to further analysis.
Characterization of the selected solid dispersion formula
Fourier transforms infrared spectroscopy (FTIR):
Samples of pure drug, Kollicoat IR and SD9 (equivalent to about 5 mg of Prednisolone) were ground, mixed with dry potassium bromide and pressed in the form of discs using hydraulic press. The discs were analyzed by FTIR spectroscopy (4000-400 cm 
Differential scanning calorimetry (DSC)
DSC was used to determine thermal behavior of Prednisolone, Indium/Zinc standards were used to calibrate the DSC temperature and enthalpy scale 21, 22 .
Powder x-ray diffraction (PXRD)
The extent of crystallinity was determined for pure drug and prepared solid dispersion using X-ray (Shimadzu, Japan) powder diffraction system equipped with Cu radiation (λ=1.54060 A • ) at a voltage of (40 Kv) and a current of (30 mA).The instrument was operated in the continuous scan mode and sample were analyzed in the range (5- 
Scanning electron microscopy (SEM):
The SEM analysis was carried out using a scanning electron microscope (SEM Tescan Vega lll Czech). Before to examination, mounted the sample on an aluminum stub using a double sided adhesive tape, then coating with a thin layer of gold (approximately 20 nm) in the vacuum to make it electrically conductive. SEM provides a high resolution images that show details of a sample surface since a high energy beam of electrons typically from 0.5 kV to 40 kV is used to scan the surface of sample to give image in a raster scan pattern 24 .
Manufacturing of colon targeted tablet of Prednisolone by direct compression method
Tablets of pure drug and solid dispersion formulations were prepared to evaluate the impact of solid dispersion on the release of the drug.
Tablets ingredients used in tablet formulation (Table 2) were accurately weighed then passed through 0.36 mm sieve to get uniform particle size. The drug and all the ingredients except lubricants were mixed and blended for 5 min. Finally, magnesium stearate was added, mixed for 2 min to coat the particle surface by lubricant evenly. The blend was compressed using 6mm punch and die on a single punch tablet machine. The formulated tablets were stored in a tightly closed container until evaluated. Based on the results of dissolution study the best formulation was selected among the six formulations for further study 25 . . In addition, weight variation was performed according to the USP specifications.
Content Uniformity test
Content uniformity was done by weighing and powdering 20 tablets.
Weigh accurately a quantity of the powder equivalent to (5 mg of Prednisolone) and transferred to 100 mL volumetric flasks containing 50 mL of phosphate buffer pH 7.4. The flasks were shaken to solubilize the drug. The volume was completed to 100 mL with the buffer, allowed to stand for 24 h to make sure complete solubility of the drug. The solution was filtered, and 1 mL of the filtrate liquid was suitably diluted and analyzed for prednisolone content spectrophotometrically at 247 nm [30] [31] [32] .
In-vitro disintegration study
The in-vitro disintegration study of the uncoated tablets was determined using the disintegration test apparatus as per USP specifications. One tablet was placed in each of the six tubes of the basket, the disc was add to each tube and running the apparatus using 900 ml of phosphate buffer pH 7.4 maintained at 37ºC. The time in seconds for complete disintegration of the tablets with no palpable mass remaining in the apparatus was measured and recorded 33 .
In-vitro dissolution study
The in vitro dissolution study was carried out as mentioned previously in section (2.2.3.2) except that one tablet of each prepared formula was placed in the dissolution vessel instead of powdered sample for 90min
Effect of different superdisintegrants addition on uncoated tablet release profile
Formulas F2SD3 and F3SD3 were designed to study the effect of different superdisintegrants addition on drug release of uncoated tablet compared with one without the addition of superdisintegrant (F4SD3), where 2% Croscarmellose, 2%Crospovidone and no superdisintegrant were used respectively.
Eudragit S100 coating of tablets for pH dependent release
For minimizing the drug release in upper GIT (stomach and small intestine) Eudragit S100 was selected as the pH dependent coating polymer. A 6% w/v Eudragit S100 coating solution was prepared using the mixture of isopropyl alcohol and acetone with the addition of 1% plasticizer-Dibutyl phthalate and used to coat tablet of optimized formula using dip coating method 34 .
Evaluation of the prepared coated tablets
Tablet of optimum formula was coated and around the selected core tablet formula and the resulted coated tablets evaluated for thickness, hardness and friability in the same way for uncoated tablets.
Disintegration test for enteric coated tablets
The disintegration test was carried out for all the formulations according to British Pharmacopeia method for enteric-coated tablets.
0.1N HCL and 7.4 pH phosphate buffer was used as disintegrating media. Six tablets were used in each case 35 .
In-vitro drug release study of coated tablets of Prednisolone
Similar dissolution conditions mentioned for powder, and uncoated tablets were used. For simulating the gastric fluid in stomach, the dissolution was accomplished in 0.1 N HCl (pH 1.2) for 2hr, in the phosphate buffer (pH 6.8) to simulate the small intestinal fluid for three hours and for another two hours in phosphate buffer (pH 7.4), simulating the colonic environment. Sample aliquots withdrawn at specific time intervals, were analyzed at 247 nm using UV-Vis Spectrophotometer 34, 36 .
Drug-excipient interactions
The physicochemical compatibilities of the drug and the used excipients were tested by FTIR. Pure Prednisolone, selected core and press coated tablets (which were previously grinded); were mixed thoroughly with potassium bromide. The potassium bromide discs were prepared by compressing the powder at a pressure in a hydraulic press and analyse in the ranges (4000-400 cm -1 ) 37 .
Statistical analysis
The results of the experiments are given as a mean values ± standard deviation (SD) and were analyzed according to one-way analysis of variance (ANOVA) at which significant results (p<0.05) and non-significant (p>0.05).
Results and Discussions
The measured solubility of Prednisolone in phosphate buffer pH7. , and PXRD result shown in figure 4 reveals the decrease in the intensity of prednisolone SD9 peak compared to pure drug which indicate decrease in crystallinity of the drug in SD9.
The results of SEM are shown in figure 5 SEM micrographs indicate that the pure drug is in the crystalline form whereas physical mixture contains both amorphous particles and some crystals of the drug. In the case of the solid dispersion, the drug particles reduced in size, some have spherical shape; which is might be one of the factors that are responsible for enhancing drug dissolution and solubility 45 .
The values of angle of repose, bulk density, tapped density, Carr's index, and Hausner ratio for the prepared uncoated powder blends of each formula was illustrated in table 3. These results estimated according to USP 33 . The results show that the prepared uncoated mixtures have acceptable flow properties and compressibility.
The results of thickness, hardness and friability of all the prepared uncoated tablets are shown in table 4.
In vitro disintegration time for all prepared Prednisolone uncoated tablet was found to be in the range of (43-420 seconds).This short disintegration time is desirable since it facilitates the dissolution and The requirement for in vitro release pattern selected for the colon targeting was no drug release up to the end of 5hrs to achieve this different Eudragit S100 coating level was examined, and the best result was using 16% coating level. The selected tablet formula was used to study the effect of coat level (thickness) on lag time of colon targeted coated tablet. The lag time of coated tablet which have tablet thickness 3.66mm was 5 hours and 20 min while for the same tablet formula which have tablet thickness 3.75mm was 7 hours as shown in figure 8 . These results
showed that as the thickness of the coat increased, the lag time increased since the time required to complete the erosion of the outer shell would be longer. The same results were reported with other related studies 49 . The FTIR spectra results showed that the drug bands didn't change significantly in the FTIR spectra of the grinded uncoated, and selected coated tablets as shown in figure 9 and the small shifting in the absorption bands was listed in table 5.
These results indicating that there is no significance evidence of chemical interaction between drug and polymer, which confirm the stability of drug.
Conclusion
Amorphous solid dispersions of prednisolone were successfully 
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